{"id":221717,"date":"2026-05-28T09:35:00","date_gmt":"2026-05-28T13:35:00","guid":{"rendered":"https:\/\/testing.news-you-need.com\/index.php\/2026\/05\/28\/multimodal-ai-biomarkers-from-biology-to-patient-stratification\/"},"modified":"2026-05-28T09:45:12","modified_gmt":"2026-05-28T13:45:12","slug":"multimodal-ai-biomarkers-from-biology-to-patient-stratification","status":"publish","type":"post","link":"https:\/\/testing.news-you-need.com\/index.php\/2026\/05\/28\/multimodal-ai-biomarkers-from-biology-to-patient-stratification\/","title":{"rendered":"Multimodal AI biomarkers: from biology to patient stratification"},"content":{"rendered":"<p><a href=\"https:\/\/dailyreporter.esmo.org\/news\/multimodal-ai-biomarkers-from-biology-to-patient-stratification\">Multimodal AI biomarkers: from biology to patient stratification<\/a><\/p>\n<p><a href=\"https:\/\/dailyreporter.esmo.org\/news\/multimodal-ai-biomarkers-from-biology-to-patient-stratification\">https:\/\/dailyreporter.esmo.org\/news\/multimodal-ai-biomarkers-from-biology-to-patient-stratification<\/a><\/p>\n<p>Publish Date: <a href=\"publish_date]\">2026-05-28 09:35:00<\/a><\/p>\n<p>Source Domain: <a href=\"dailyreporter.esmo.org\">dailyreporter.esmo.org<\/a><\/p>\n<ul>\n<li>\n<p><strong>Integration of Diverse Data Types<\/strong>: Artificial intelligence (AI) is driving the development of next-generation biomarkers by integrating histology slides, genomic and transcriptomic profiles, radiology scans, and clinical records, aiming for comprehensive biological insights.<\/p>\n<\/li>\n<li>\n<p><strong>Scalability and Real-Time Predictions<\/strong>: These AI models can generate scalable, biologically grounded insights at little added cost and produce predictions in near real-time, facilitating timely clinical decisions.<\/p>\n<\/li>\n<li>\n<p><strong>Multimodal AI Contributions<\/strong>: Each integrated modality (tissue morphology, genomics, transcriptomics, proteomics, and clinical records) provides unique information to better predict outcomes like tumor heterogeneity and immune infiltration.<\/p>\n<\/li>\n<li>\n<p><strong>Challenges and Validation<\/strong>: The success of these AI-generated biomarkers depends on their reproducibility across diverse patient populations, regulatory approval, and understanding of the underlying biological mechanisms to build clinician trust.<\/p>\n<\/li>\n<li>\n<p><strong>Complementing Traditional Biomarkers<\/strong>: These new AI biomarkers are designed to complement rather than replace existing assays, particularly in situations where tissue and sequencing data are limited.<\/p>\n<\/li>\n<li>\n<p><strong>Future Impact on Precision Oncology<\/strong>: As AI matures and more clinical data becomes accessible, multimodal AI biomarkers could become central to modern cancer care, offering advancements in diagnosis, treatment, and equity in oncology globally.<\/p>\n<\/li>\n<li>\n<p><strong>Role of Collaboration<\/strong>: Progress in this field relies on the collective efforts of academic labs, translational research groups, clinical partners, and technology companies.<\/p>\n<\/li>\n<li>\n<p><strong>StratifAI&#8217;s Contributions<\/strong>: StratifAI is leading the development of Polaris\u2122, a multimodal AI-driven biomarker discovery platform that uses routinely available clinical data to identify novel prognostic and predictive biomarkers for individualized cancer treatment strategies.<\/p>\n<\/li>\n<\/ul>\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Multimodal AI biomarkers: from biology to patient stratification https:\/\/dailyreporter.esmo.org\/news\/multimodal-ai-biomarkers-from-biology-to-patient-stratification Publish Date: 2026-05-28 09:35:00 Source Domain:&#8230;<\/p>\n","protected":false},"author":1,"featured_media":221719,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"\/var\/esmo\/storage\/images\/media\/esmo-daily-reporter\/images\/contributed-articles\/esmo-ai-hub-banner\/20111888-1-eng-GB\/esmo-ai-hub-banner_reference.jpg","fifu_image_alt":"","footnotes":""},"categories":[14],"tags":[20],"class_list":["post-221717","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-artificial-intelligence","tag-artificial-intelligence"],"_links":{"self":[{"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/221717"}],"collection":[{"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/comments?post=221717"}],"version-history":[{"count":1,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/221717\/revisions"}],"predecessor-version":[{"id":221721,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/221717\/revisions\/221721"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/media\/221719"}],"wp:attachment":[{"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/media?parent=221717"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/categories?post=221717"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/tags?post=221717"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}